Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice.

Autor:in

Magnusson, Sofia E; Karlsson, Karin H; Reimer, Jenny M; Corbach-Söhle, Silke; Patel, Sameera; Richner, Justin M; Nowotny, Norbert; Barzon, Luisa; Bengtsson, Karin Lövgren; Ulbert, Sebastian; Diamond, Michael S; Stertman, Linda;

Schlagwörter

Adjuvants, Immunologic/administration & dosage*; Animals; Antibodies, Neutralizing/blood; Antibodies, Viral/blood; Cytokines/immunology; Female; Immunity, Cellular; Immunity, Humoral; Immunoglobulin G/blood; Mice; Mice, Inbred BALB C; Th1 Cells/immunology; Th2 Cells/immunology; Viral Envelope Proteins/immunology*; West Nile Fever/prevention & control*; West Nile Virus Vaccines/immunology*; West Nile virus/classification*;

ISSN/eISSN

0264-410X -

WoS ID

WOS:000331502000008